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Flexible UWB monopole antennas were implemented in a wearable head device and tested for measuring and 
detecting brain atrophy and lateral ventricle enlargement for patients with Alzheimer’s disease.  
 
Take-Home Messages  
• A wearable device was developed with electromagnetic sensors in order to non-invasively monitor the 
progress of brain atrophy and lateral ventricle enlargement as a result of Alzheimer’s disease. 
• The developed wearable RF device is capable of detecting the progression of brain atrophy and lateral 
ventricle enlargement successfully. 
• The work in this study targets Alzheimer’s disease and aims to develop a non-invasive device for monitoring 
the progression of the disease in patients. 
• The breakthrough in this work is the development of a wearable device that uses RF sensors for detecting 
changes in the brain as a result of Alzheimer’s disease.
Non-Invasive Wearable RF Device Towards 
Monitoring Brain Atrophy and Lateral Ventricle 
Enlargement 
Imran M. Saied, Tughrul Arslan, Senior Member, IEEE 
 
 Abstract - Alzheimer’s disease is the most common form of neurodegenerative disease and a leading cause of dementia today. A 
pathological effect of Alzheimer’s disease is brain atrophy, which is the progressive shrinkage of the brain volume and weight. 
Another effect of Alzheimer’s disease is the enlargement of lateral ventricles in the brain. Currently, MRI and CT scanners can 
detect and show images of the brain during different stages of Alzheimer’s disease. However, its limited accessibility, high costs, 
and static structure make it inconvenient for some to use. This paper presents the design and novel application of a wearable 
device comprising of flexible microwave antennas, with an operating frequency range of 800 MHz to 2.5 GHz, that detects the 
progression of brain atrophy and lateral ventricle enlargement in patients with Alzheimer’s at the earliest stage possible. The 
operating principle of the antennas are simulated in near field using CST and the device is experimentally validated using lamb 
brain samples and samples representing cerebral spinal fluid (CSF). The measured reflection coefficients (S11) and transmission 
coefficients (S21) were found to correlate with changes in brain volume and changes in CSF volume successfully, thus giving an 
indication of the progression of Alzheimer’s disease in a patient. 
 
Keywords — Electromagnetic, RF sensing, microwave medical imaging, RF medical diagnosis, non-invasive monitoring 
 
I. INTRODUCTION1 
EURODEGENERATIVE diseases result from a progressive 
loss of structure or function of neurons, including the 
death of neurons. Alzheimer’s disease is the most common 
form of neurodegenerative disease and is considered the 
sixth leading cause of death in the United States [1]-[2]. 
According to the Alzheimer’s Association in U.S.A., 
Alzheimer’s disease is the most expensive disease in the U. 
S., costing more than cancer and heart disease. In addition, 
the Alzheimer’s Society in the UK reported that there are 
more than 520,000 people with Alzheimer’s disease out of 
the 850,000 people suffering from dementia, with numbers 
expected to rise to 1 million by 2025. Symptoms include: 
substantial memory loss, problems with language, 
disorientation, loss in concentration, mood swings, 
behavioral issues, and eventually leading to loss of bodily 
functions and death [3]. The life expectancy of those 
diagnosed with Alzheimer’s disease is between 3 to 9 years 
[3].  
One of the distinguishing features of Alzheimer’s disease 
is the progressive shrinkage of the brain due to atrophy (or 
the shrinkage of the brain) [4]. It has been found that the 
brain volume can reduce by more than 22% of the normal 
brain in Alzheimer’s patients and that the brain’s weight 
after Alzheimer’s disease frequently falls under 1 kg as 
compared to the normal adult brain weight of 1.2 to 1.4 kgs 
[5]. Another distinguishing pathological change that occurs 
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as a result of Alzheimer’s disease is that the lateral ventricle 
enlarges as the disease progresses. 
Detection and imaging of neurodegenerative diseases, 
such as Alzheimer’s disease, has been the focus of research 
studies in the past decade. In previous studies, computed 
tomography (CT) and magnetic resonance imaging (MRI) 
were used to diagnostically rule out other causes of 
dementia [6]. Structural MRI is a recently developed tool 
that can be used to assess atrophy and changes in tissue 
characteristics [6]. An advantage of MRI is its availability 
and has been recommended extensively in the diagnosis of 
dementia in European and U.S. practices [6]. However, this 
comes at a high cost, which makes it difficult for some 
patients to pay for, and may not be readily available in 
certain countries. In addition, patients with a severe case of 
Alzheimer’s disease may not tolerate MRI procedures, or 
CT scans. 
In recent years, applications have been developed that 
utilized microwave technology to detect and image diseases 
in the brain such as stroke and brain tumor. An initial 
approach was discussed about in [7] where a Vivaldi 
antenna operating at a frequency range of 3 GHz to 10 GHz 
was simulated. The study reported it was able to detect a 
difference in scattered signals from a healthy head phantom 
and a head phantom that contained a tumor. However, due 
to the high frequency range the penetration was not strong 
enough to detect any anomalies beyond the region near the 
skull. Another Vivaldi antenna was proposed in [8] that 
operates between 1 GHz to 4 GHz. This antenna was able 
detect the occurrence of stroke in the head region. 
However, the study utilized a switching system using 
microwave coaxial switches in order to connect the   
elements of the array. As a result, the system was large and 
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3 
therefore, could only be used for static testing.  A small 
portable UWB antenna system was discussed about in [9] 
and [10]. The portable system contained a portable vector 
network analyzer (VNA) that was custom-made for this 
setup. Its purpose was to replace the more conventional and 
bulkier VNA that would have limited the portability of this 
device.  A textile-based antenna was discussed in [6] for 
proposed use in microwave head imaging. This antenna 
operated in the range of 1.2 GHz to 6 GHz. Although the 
antenna provided good SAR values and S11 results which 
are in line with the specifications need for a safe head 
imaging system, the size of the antenna was too big to 
create a proper array. In [11] and [12], a novel wearable 
antenna array system was designed for head imaging. The 
wearable head imaging system utilizes 8 flexible directional 
UWB monopole antennas. To ensure flexibility, the 
antennas were created using a very thin flexible 
polyethylene terephthalate (PET) substrate with a thickness 
of 75 um. The antennas operated at a frequency range 
between 1.3 GHz to 3.5 GHz that would allow sufficient 
penetration and resolution. The flexible nature of the 
antenna and implementation in clothing fabrics makes the 
device wearable and portable to the user. The device was 
simulated and tested using a VNA and was found to have 
satisfactory results for S11. In addition, SAR value was 
found to be well below the maximum limit, thus making it a 
safe device to use on the human body. However, the device 
is fairly novel and more studies need to be performed in 
order to see how well the system works. 
This paper presents a novel application of a low-cost and 
non-invasive wearable device to monitor the progression of 
brain atrophy and lateral ventricle enlargement in patients 
with Alzheimer’s disease. Simulation and experimental 
results of the antennas in the device were used to detect the 
progression of brain atrophy using real lamb brains that 
were placed in a model of a human skull. The antennas used 
were a monopole, bi-directional antenna, created using a 
very thin flexible polyethylene terephthalate (PET). A 
vector network analyzer (VNA) was used to generate the 
signals to the antennas and also receive them for analysis. 
The reflection coefficients (S11) and transmission 
coefficients (S21) of the antennas were captured and 
analyzed in order to determine whether a correlation exist 
between the brain atrophy and lateral ventricle enlargement 
rates and captured measurements. To the best of the 
authors’ knowledge, no prior research study has been made 
using this technology. 
II. ANTENNA DESIGN 
The antennas were designed in order to be conformable 
and directional. In order to utilise a radar-based approach 
for microwave imaging, the designed antennas should 
exhibit ultra-wideband (UWB) performance. For this 
application, a planar monopole antenna is one of the best 
candidates due to its low-profile configuration as compared 
to a Vivaldi antenna, which has a high-profile structure 
along the direction of propagation, thus making it 
unsuitable for wearable applications. At low frequency 
levels, the antennas can achieve more penetration but less 
resolution. At high frequencies, on the other hand, the 
antennas can achieve less penetration but higher resolution. 
By using UWB antennas, the aim is to achieve good 
penetration and resolution for the antennas, so that they can 
be utilized eventually for radar-based imaging. Fig. 1 (a) 
shows a screenshot of the fabricated UWB antenna that was 
designed and used in this study, and 1 (b) shows the design 
of the UWB antennas. The values of the antenna’s 
dimensions as shown in the schematic diagram are the 
following (in mm): , , , , 
, and . 
 
             
                       (a)                                          (b)  
Fig. 1. (a) Screenshot of fabricated UWB antenna. (b) 
Schematic diagram of the designed antenna.  
 
The feeding line is made of a co-planar waveguide 
(CPW) structure where its characteristic impedance is 50 
ohms, while a trapezoidal patch was selected as the 
radiating element in order to provide a smooth transition of 
the input current from the feeding line to the radiating 
elements, ensuring good impedance matching across the 
intended frequency. The substrate used for the antenna is 
PET that has a dielectric constant of 2.4 and a thickness of 
75 µm, which provides flexibility to the antenna structure. 
The metallization is only on one side of the antenna 
structure.  
III. METHODS AND PROCEDURES 
A. Simulation Methods 
The simulations for testing the antenna measurements for 
brain atrophy and lateral ventricle enlargement were 
performed in near field using CST Microwave Suite. In 
order to simulate the brain atrophy tests, a realistic human 
head model was used that contained several tissues, such as: 
skin, skull, blood, white matter, and gray matter. A pair of 
monopole antennas were designed in CST and defined to be 
have material properties associated with PET material. The 
dielectric constant of the substrate used is 2.4. To ensure 
good penetration into the head, a working frequency 
between 0.8 and 3 GHz was utilized in the design of this 
antenna. These antennas were placed on each side of the 
human head model next to the skin and near field 
measurements were obtained in the simulations. 
Characteristics of brain atrophy were simulated by 
uniformly reducing the size of the inner objects (i.e., white 
matter and gray matter), replacing the gap with 
cerebrospinal fluid, and keeping the size of the other objects 
(i.e. skull, skin, and blood) constant. After specifying the 
size of the brain, the simulation would be performed to 
capture S11 and S21 data from the antennas based on the 
different sizes of the brain in simulation. Fig. 2 shows the 
screenshot of the simulation model used in CST  
 
 
Fig. 2. Human head CST model and antennas that were 
used for simulations of brain atrophy and lateral ventricle 
enlargement.  
 
In order to simulate lateral ventricle enlargement in CST, 
the same human head model was used with the same 
properties. However, an additional object was placed inside 
the gray matter layer and was defined to have properties of 
cerebral spinal fluid (CSF). This last layer was first defined 
to have a very small volume within the brain. As in the 
previous simulation for brain atrophy, the two PET 
antennas were designed and placed on the sides of the outer 
layer. To show the lateral ventricle size expanding, the size 
of the object corresponding to cerebral spinal fluid would 
be enlarged to different sizes. S11 and S21 data would then 
be measured and compared for different sizes of lateral 
ventricles within the brain. 
B. Experimental Methods 
The wearable device was constructed in a hat-like shape. 
The advantage of this structure is that it can be conveniently 
worn by patients. 6 monopole antennas are then arranged 
around the inner side of the absorber using Velcro, and the 
distance between each antenna is approximately 17 mm. 
The antennas are separated from the absorber using 5 mm 
thick foam whose dielectric constant is similar to that of air 
in order to maintain the antennas’ integrity and not have its 
signals affected. The top of the device is made hollow in 
order to accommodate wires going from the antennas to the 
vector network analyzer (VNA), which controls the signals 
being generated and received by the antennas.  
The system setup that was used for experiments is shown 
in Fig. 3. The experimental setup consists of a PC, VNA, 
wearable RF device, and the skull model which contains the 
fabricated phantoms. The experiments were conducted 
using a host PC that was connected to the VNA via a GPIB. 
The PC allows the user to setup the VNA and send a 
command to the VNA to start generating signals and 
capturing S11 and S21 data from the ports directly into the 
PC using a built-in software. The VNA that was used for 
the experiments is a HP 8753 that has a frequency range of 
300 kHz to 3 GHz with a dynamic range of up to 100 dB. 
The wearable device was connected to 50-ohm ports on the 
VNA using SMA cables. Calibration was performed by first 
attaching the antennas inside the wearable device. Then the 
VNA was calibrated using the open, short, and load 
connections for each antenna. The device would then be 
placed on top of the skull model with no phantom inside. 
The S11 measurement would then be recorded and utilized 
as the benchmark for all other measurements.  
 
 
Fig. 3.  Experimental setup consisting of Host PC, VNA, 
and Skull Model with wearable RF device. 
 
For the experiments, a life-size skull model was used 
containing similar indentations that are present in human 
beings. In addition, the skull model could be disassembled 
easily, allowing contents to be placed inside. To create a 
realistic representation of a human brain, real lamb brains 
were used and placed inside the skull model. A typical lamb 
brain is about 1/10th the size of a human brain. As a result, 
10 whole lamb brains were molded into the skull cavity and 
frozen in order to provide the representation of a complete 
normal brain structure with a volume of 1200 cm3.  
To mimic the characteristics of brain atrophy in this first 
experiment, a measured amount of the lamb brain sample 
was removed uniformly around the outer layer for each 
atrophy case and replaced with a layer of artificial phantom 
that represents cerebrospinal fluid (CSF). This phantom was 
fabricated using salty water, agar, and a color dye to make 
it distinguishable in the experiments. For example, in the 
first experiment, 5% of the lamb brain was removed 
uniformly around the outer layer of the lamb brain. This 
empty region is replaced with an artificial phantom to 
mimic the characteristics of CSF. In the second experiment, 
another 5% of the lamb brain was removed again and 
replaced with a thicker layer of the artificial CSF phantom, 
resulting in a total decrease of 10% from the original 
complete model. Finally, for the third and fourth 
experiments, a 20% reduced-sized lamb brain model and a 
25% reduced-sized lamb brain model were used 
respectively. Figs. 4(a)-(e) show images of the actual lamb 
brain skull models used in the brain atrophy experiments. 
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Fig. 4. Images showing different compositions of lamb 
brains and outer CSF layer (light brown color) inside the 
skull model representing brain atrophy for the following 
cases: a) full brain volume, b) 5%, c) 10%, d) 20%, and e) 
25% brain atrophy, respectively. 
 
To perform the second part of the experiments for 
detecting lateral ventricle enlargement, objects were created 
to mimic the CSF inside the brain. The same full-brain 
lamb brain sample was used and placed in the skull model; 
however, a 6-mm diameter cavity was created in both 
halves of the brain in order to insert the CSF object inside 
the brain. This 6-mm diameter cavity was created by first 
filling both halves of the skull model with lamb brains and 
then placing a plastic ball in the center of these halves. The 
model would then be frozen to ensure that the lamb brains 
remain fixed in the same location. Once frozen, the plastic 
ball would be removed and the resulting cavity is created. 
Fig. 5 (a) shows the resulting cavity that was created in one 
half of the skull model. 
 To create the CSF objects, different sizes of an artificial 
phantom were created using water, salt, and agar in order to 
create a high dielectric object and inserted into the cavity 
(shown in Figs. 5 (b)-(e)). Once inserted into the cavity, the 
lamb brains would be allowed to thaw out so that it can 
conform around the shape of the CSF object and fill up any 
gaps left behind. A green color dye was utilized to make the 
objects distinguishable in the experiments. The volumes of 
the samples were: 1) 22.6 mm3, 2) 56.5 mm3, 3) 113 mm3, 
and 4) 226 mm3.  
 
Fig. 5. Images of: (a) frozen lamb brain with 6-mm 
diameter cavity and (b)-(e) different-sized CSF samples 
(light green color) used in the experiments: b) 22.6 mm3, c) 
56.5 mm3, d) 113 mm3, and e) 226 mm3. 
IV. RESULTS 
A. Simulation Results 
Fig. 6 shows changes in S11 plots for different brain 
atrophy cases compared to the S11 plot of a normal full-size 
brain with a mean ± standard deviation of 7.4400 ± 
5.8268. It can be noticed that as the brain volume decreases, 
there is an overall downward shift in the S11 graph 
indicating more loss in the signal as they do not get 
reflected back. 5% brain atrophy shows an insignificant 
change in the S11 plots due to the small amount of change in 
the brain size. However, for the case of 20% and 25% brain 
atrophy, at 1.5 GHz, the signal loss is almost double the S11 
value associated with the full brain case, thus validating the 
antennas’ capability of detecting brain atrophy in reflection 
mode.  
Fig. 7 shows changes in S21 plots for different brain 
atrophy cases based on simulations compared to the S21 of a 
normal brain with a mean ± standard deviation of 
57.3593 ± 7.4864. The plots indicate that as the brain’s 
size decreases, a downward shift in the S21 plots is present, 
indicating that the signal is not transmitted properly to the 
other antenna due to the decrease in brain tissues and 
increase in the higher-dielectric CSF layer that absorbs 
most of the transmitted signals. 
 
 
Fig. 6. Simulation plots showing changes in reflection 
coefficient (S11) between a normal brain and brain with 5%, 
10%, 20%, and 25% brain atrophy. 
 
This trend can be seen in the case of 20% and 25% brain 
atrophy where the change in S21 is between 20 and 40 dB 
across the bandwidth between 0.84 GHz to 2.4 GHz, which 
corresponds with the antennas’ operating frequency range. 
This proves that based on simulations, the antennas are able 
to detect brain atrophy in transmission mode. 
 
 
Fig. 7. Simulation plots showing changes in transmission 
coefficient (S21) between a normal brain and brain with 5%, 
10%, 20%, and 25% brain atrophy. 
 
Simulations for lateral ventricle enlargement were also 
conducted and results were analyzed. Fig. 8 shows changes 
in S11 plots obtained from simulations between a brain with 
no CSF in the brain, with a mean ± standard deviation of 
7.3700 ± 5.6154, and one with CSF levels increased by 2 
times and 4 times in the lateral ventricles, respectively.  
As the amount of cerebral spinal fluid increases in the 
brain from 2 times to 4 times the amount, the S11 plots 
shows an increasing downward shift in the reflected signal, 
which indicates an increased loss in the signal. This is due 
to the higher dielectric difference of the CSF object 
compared to brain tissues. The change in the S11 loss 
increases from 11 dB to 17.5 dB at 1.35 GHz when a 
quadruple increase in CSF object occurs in the lateral 
ventricle. This validates the antennas’ ability to detect 
lateral ventricle enlargement in the reflection mode. 
 
Fig. 8. Simulation plots showing changes in S11 between a 
brain with normal CSF levels and brain with 2x and 4x CSF 
levels in the lateral ventricles. 
 
Simulations were also performed to investigate the 
transmission characteristics due to increasing lateral 
ventricle sizes and shown in Fig. 9.  
 
 
Fig. 9. Simulation plots showing changes in S21 between a 
brain with normal CSF levels and brain with 2x and 4x CSF 
levels in the lateral ventricles. 
 
In Fig. 9, the plot for a brain with no CSF in the ventricle 
has a mean ± standard deviation of 57.2078 ± 6.9762. As 
the levels of CSF increases, a downward shift is present in 
the S21 plots that is significant between 0.84 GHz and 1.5 
GHz. This loss is due to the CSF in between that hinders 
the signal from transmitting to the other antenna. In 
addition, when the size of the CSF increases from 2 times to 
4 times, the S21 plot at 1.05 GHz shows a sudden increase in 
the loss from 86 dB to 150 dB. This result validates that 
the antennas are capable of detecting lateral ventricle 
enlargement in the transmission mode.  
Table I summarises the statistical results of the simulation 
models for brain atrophy and increasing ventricle cases. 
The mean, standard deviation, p-value (p), and resulting 
null hypothesis (h) have been recorded for each of the 
cases. For this study, the significance level of p was chosen 
to be at 0.05 or 5%. In addition, h = 0 represents that the 
null hypothesis was not rejected, while h = 1 indicates the 
rejection of the null hypothesis, respectively. 
 
   
Based on the statistical data provided in Table I, it can be 
seen that for all cases, p is less than 0.05, and therefore the 
null hypothesis can be rejected, thus concluding that the 
antennas are capable of detecting changes in brain atrophy 
and lateral ventricle sizes in the operating frequency range. 
B. Experimental Results 
Results were obtained from experiments and compared 
with those from simulations to verify antennas’ capability 
of detecting brain atrophy and lateral ventricle enlargement. 
Figs. 10 and 11 show the plots of changes in S11 and S21 
respectively between different cases of brain atrophy and a 
normal full brain. The S11 plot of a normal full brain has a 
mean ± standard deviation of 9.1587 ± 6.1556, while the 
S21 plot has a mean ± standard deviation of 25.1777 ± 
7.0757, respectively. 
 
 
Fig. 10. Plots showing changes in reflection coefficient 
(S11) between a normal brain and brain with 5%, 10%, 20%, 
and 25% brain atrophy obtained from experiments. 
 
TABLE I 
STATISTICAL RESULTS OF SIMULATION MODELS 
Simulation Cases 
 
P-Value 
(S11) 
       
H 
(S11) 
 
P-Value 
(S21) 
        
H 
(S21) 
Brain Atrophy     
5% Brain Atrophy 0.0496 1 0.0367 1 
10% Brain Atrophy 0.0378 1 5.97E-10 1 
20% Brain Atrophy 0.0037 1 2.78E-12 1 
25% Brain Atrophy 0.0049 1 7.36E-24 1 
 
Lateral Ventricle 
Enlargement 
    
2x Increase of CSF 0.0401 1 0.0286 1 
3x Increase of CSF 0.0225 1 3.41E-8 1 
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Fig. 10 shows that as brain atrophy increases, the resulting 
S11 plots displays more loss in the signal and therefore an 
oscillating downward shift in the overall trend between 0.8 
to 2.5 GHz. Oscillations may be due to noise that is emitted 
from the surroundings in the experimental setup. However, 
the overall trend is expected based on simulation results and 
verifies the antennas’ ability to detect brain atrophy in the 
reflection mode. In particular, the change in S11 loss 
increases significantly to 30 dB, 40 dB, and 55 dB for 
10%, 20%, and 25% brain atrophy cases, respectively. 
  
 
Fig. 11. Plots showing changes in S21 between a normal 
brain and brain with 5%, 10%, 20%, and 25% brain atrophy 
obtained from experiments. 
 
Similarly, S21 plots in Fig. 11 show that as brain atrophy 
increases, there is more loss displayed in the transmitted 
signal due to the increasing presence of a thicker CSF layer 
that hinders the signal from transmitting to the receiving 
antenna. This leads to a larger difference in S21 data that can 
be seen in 10%, 20%, and 25% brain atrophy cases, 
respectively. In addition, both the S11 and S21 plots show 
this behavior occurring in the frequency range of 0.85 GHz 
to 2.6 GHz which corresponds with the operating frequency 
of the antenna design. 
Experiments were also performed for lateral ventricle 
enlargement and its resulting S11 and S21 plots are shown 
Figs. 12 and 13 respectively. The S11 plot for no CSF has a 
mean ± standard deviation of 10.0821 ± 5.9123, while the 
S21 plot has a mean ± standard deviation of 25.6884 ± 
4.7394, respectively. 
 
 
Fig. 12. Plots showing changes in S11 signals obtained from 
experiments for increasing volumes of CSF as a result of 
lateral ventricle enlargement. 
Results in Fig. 12 shows a similar trend found in the 
simulation results where the S11 loss increases as a result of 
increasing CSF volume, due to the change in the dielectric 
properties. This pattern is also present in the S21 plots in 
Fig. 13 as well where the transmitted signal is not 
propagated completely to the receiving antenna due to the 
increasing CSF sample that hinders the signal in between. 
This characteristic can be seen between 0.86 to 1.7 GHz, 
where the change in S21 is increased to almost three times 
the original value. Therefore, the antennas are capable of 
detecting lateral ventricle enlargement in both reflection 
and transmission modes. 
 
 
Fig. 13. Changes in S21 plots obtained from experiments for 
increasing volumes of CSF as a result of lateral ventricle 
enlargement. 
 
Table II summarises the statistical results of the 
experiments for brain atrophy and increasing ventricle 
cases. As in Table I, p-value (p) and resulting null 
hypothesis (h) have been recorded for each of the cases, 
while significance level of p was chosen to be at 0.05 or 
5%. It can be seen that for all the experiments, p is less than 
0.05, and therefore the null hypothesis is rejected. As a 
result, this concludes that the antennas are genuine in 
detecting changes in brain atrophy and lateral ventricle 
sizes in practical applications as well. 
                      
 
TABLE II 
STATISTICAL RESULTS OF EXPERIMENTS 
Experiments 
 
P-Value 
(S11) 
        
H 
(S11) 
 
P-Value 
(S21) 
        
H 
(S21) 
Brain Atrophy     
5% Brain Atrophy 0.0498 1 1.47E-11 1 
10% Brain Atrophy 0.0484 1 6.67E-4 1 
20% Brain Atrophy 0.0249 1 3.84E-14 1 
25% Brain Atrophy 0.0038 1 4.82E-17 1 
 
Lateral Ventricle 
Enlargement 
    
22.6 mm3 CSF 0.0442 1 0.0389 1 
56.5 mm3 CSF 0.012 1 0.0288 1 
113 mm3 CSF 5.8E-7 1 0.0248 1 
226 mm3 CSF 1.41E-11 1 0.0014 1 
     
 
            
 A closed form expression can also be proposed that 
provides a general relationship between the S-parameters 
and the amount of either brain atrophy or lateral ventricle 
enlargement that occurs in the brain. To obtain such 
expressions, curve fitting analysis was performed in 
MATLAB on the measured data for the cases of brain 
atrophy and lateral ventricle enlargement, separately. Using 
the curve fitting toolbox in MATLAB, a general expression 
was obtained for percentage change in S11 and S21 
parameters with respect to the level of brain atrophy and 
lateral ventricle enlargement separately.  
 In order to verify that the obtained equations fit the 
model, the following conditions were evaluated as part of 
the goodness of fit criteria for this study: 
 
1. Sum of squares due to error (SSE) should be close to 0. 
2. R-square should be greater than 0.85 and less than 1. 
3. Adjusted R-square should be greater than 0.85 and less 
than 1. 
4. Root mean squared error (RMSE) should be close to 0. 
Based on these conditions, the following closed form 
expressions were obtained for percentage change in S11 (1) 
and S21 (2) with respect to level of change in brain atrophy: 
 
 
     (1) 
 
 
 
 
   (2) 
 
 
where x is the percentage of brain atrophy. In addition, the 
curve fitting approach was utilized to obtain closed form 
equations for percentage change in S11 (3) and S21 (4) 
respectively based on the level of lateral ventricle 
enlargement in the brain. 
 
 
  (3) 
 
 
 
 
  (4) 
 
  
                                             
where y is the volume of CSF inside the lateral ventricles. 
Finally, the specific absorption rate (SAR) was also 
calculated through simulations in CST to investigate the 
effects of the EM wave exposure from the device to the 
human head. The maximum limit of SAR approved by the 
UK government is 2W/kg for 10g of tissue mass, which 
must be complied to ensure safe operation of the wearable 
device. At 1.5 GHz, the SAR values were found to be 
0.0115 W/kg, 0.115 W/kg, and 1.15 W/kg for transmitted 
power of 1 mW. 10mW, and 100 mW respectively. At 2.5 
GHz, the SAR values were found to be 0.0121 W/kg, 0.122 
W/kg, and 1.2112 W/kg for 1 mW, 10 mW, and 100 mW 
respectively. Finally, at 3 GHz, the calculated SAR values 
were 0.135 W/kg, 0.133 W/kg, and 1.355 W/kg for 1 mW, 
10mW, and 100 mW respectively. It can be seen that for 
each frequency, the calculated SAR values are well below 
the maximum limit indicated by the UK government. In 
addition, the EM waves absorbed by the biological tissue 
increases linearly with the transmitted power. Based on 
these results, it is therefore recommended to limit the 
transmitted power to below 100 mW to ensure safe 
operation of the wearable device. 
V. CONCLUSIONS 
Simulations and experiments were performed to verify 
the design of a novel device capable of monitoring the 
progression of brain atrophy and lateral ventricle 
enlargement in the brain as a result of Alzheimer’s disease. 
The device contained UWB antennas that operated between 
0.8 and 3 GHz. The non-invasive monitoring approach and 
wearable design makes it a novel tool for medical 
diagnostic devices. Results from simulations and 
experiments show that the antennas in the device are 
capable of detecting different levels of brain atrophy and 
lateral ventricle enlargement in both the reflection and 
transmission modes, thus providing a promising tool for 
monitoring patients with Alzheimer’s disease. This study is 
the foundation for future work to be performed in 
developing early-stage Alzheimer’s disease detection 
approaches. Future work will focus on investigating 
techniques that adapt and test the device on different head 
sizes. This would lead to a revolutionary non-invasive 
technology that would solve a major challenge of 
Alzheimer’s disease and provide a way for early diagnosis. 
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